Single Nucleotide Polymorphism-based Biomarker in Primary Hypertension

In conclusion, SNP research in primary hypertension is rapidly evolving with emerging technologies and methodologies that have the potential to transform the knowledge about genetic basis related to the condition. These advances hold promise for personalized prevention and treatment strategies tailored to an individual's genetic profile ultimately improving patient outcomes and reducing healthcare costs.PMID:38621507 | DOI:10.1016/j.ejphar.2024.176584
Source: European Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research